Measuring adherence to inhaled control medication in patients with asthma: Comparison among an asthma app, patient self-report and physician assessment.

Publication Year: 2023

DOI:
10.1002/clt2.12210

PMCID:
PMC9930432

PMID:
36825517

Journal Information

Full Title: Clin Transl Allergy

Abbreviation: Clin Transl Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST JAF is the co‐founder of SME, which owns the InspirerMundi app. The authors declare that they have no competing interests."

Evidence found in paper:

"We thank the participants and centres involved in this study. We would also like to acknowledge all members of the Inspirers group (https://paceit.med.up.pt/sample‐page/inspirers‐group/) and Mundipharma‐Portugal for supporting the dissemination of the InspirerMundi app. This study was funded by the European Regional Development Fund through the following programs: POCI‐01‐0145‐36 FEDER‐029130 (‘mINSPIRE—mHealth to measure and improve adherence to medication in chronic obstructive respiratory diseases ‐ generalisation and evaluation of gamification, peer support and advanced image processing technologies’) cofunded by the COMPETE2020 (Programa Operacional Competitividade e Internacionalização), Portugal 2020 and by Portuguese Funds through Fundação para a Ciência e a Tecnologia. This study was supported by National Funds through Fundação para a Ciência e a Tecnologia, IP, within the research and development unit of CINTESIS (reference UIDB/4255/2020)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025